On Wednesday 22nd March 2017, the UK National Screening Committee recommended that the Government should not introduce routine screening of pregnant women for group B Strep.
We are hugely disappointed by this recommendation.
Group B Streptococcus (GBS or Strep B) is the UK’s most common cause of life-threatening infection in newborn babies – causing sepsis, meningitis and pneumonia.
Group B Strep is carried by around 20-30% of the population and, on average, in the UK:
- 2 babies a day develop group B Strep infection
- 1 baby a week dies from group B Strep infection
- 1 baby a week survives with disability
We profoundly disagree with the UK National Screening Committee’s recommendations, and are disappointed that they are ignoring international evidence, as well as the wishes of families and health professionals.
Jane Plumb MBE, Chief Executive of Group B Strep Support:
“The Government will be making the wrong decision if it accepts the UK National Screening Committee’s recommendations against a group B Strep screening programme.”
“There is a huge amount of international evidence demonstrating the benefits of screening pregnant women for group B Strep. For example, since the USA first recommended screening in 1996, the incidence of group B Strep infection in babies has halved without concomitant harms. Yet the UK has seen a rise of 30% since 2000, despite our risk-based prevention strategy introduced in 2003.”
“This evidence seems to have been ignored, despite us and others highlighting it during this during the public consultation.”
“The UK National Screening Committee position is unacceptable. How can they advocate denying pregnant women the opportunity to make an informed choice about their and their baby’s care?”
Professor Philip Steer, Chair of the Group B Strep Support Medical Advisory Panel:
“I am disappointed that, once again, the UK National Screening Committee has chosen to deny women using the NHS the option to choose group B Strep screening.
Women found by chance to be carriers of group B Strep are offered intravenous penicillin in labour to protect their baby from this potentially devastating illness, and yet this is being denied to other carriers whose status remains unknown.”
Please sign up to our email list to be kept up-to-date on the next steps in our campaign to stop GBS infection in babies.